Mirae Asset Global ETFs Holdings’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-57,495
Closed -$884K – 3137
2025
Q4
$884K Buy
57,495
+1,150
+2% +$12.7K ﹤0.01% 1591
2025
Q3
$557K Sell
56,345
-9,254
-14% -$96.3K ﹤0.01% 1821
2025
Q2
$651K Sell
65,599
-20,822
-24% -$219K ﹤0.01% 1669
2025
Q1
$1.13M Buy
86,421
+1,625
+2% +$21.5K ﹤0.01% 1440
2024
Q4
$1.08M Buy
84,796
+2,206
+3% +$26.7K ﹤0.01% 1502
2024
Q3
$919K Buy
82,590
+5,775
+8% +$63.7K ﹤0.01% 1588
2024
Q2
$864K Buy
+76,815
New +$894K ﹤0.01% 1534

Other funds holding DVAX

Mirae Asset Global ETFs Holdings's DVAX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 57,495 shares — an estimated $884K sold.

Mirae Asset Global ETFs Holdings first reported a position in DVAX in Q2 2024 and held it in 7 quarters. The position peaked at $1.13M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 57,495 Dynavax Technologies shares in Q1 2026, an estimated $884K.
  • Mirae Asset Global ETFs Holdings first reported a position in Dynavax Technologies in Q2 2024 and held it in 7 quarters.
  • Mirae Asset Global ETFs Holdings's Dynavax Technologies position peaked at $1.13M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.